BROOKFIELD Corp ON Invests $9.71 Million in Sabra Healthcare REIT, Inc. $SBRA

BROOKFIELD Corp ON bought a new position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 504,943 shares of the real estate investment trust’s stock, valued at approximately $9,710,000.

Other large investors have also recently bought and sold shares of the company. Sumitomo Mitsui Trust Group Inc. lifted its stake in Sabra Healthcare REIT by 6.8% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after acquiring an additional 203,226 shares during the period. Principal Financial Group Inc. increased its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the period. Legal & General Group Plc raised its holdings in shares of Sabra Healthcare REIT by 16.5% during the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after purchasing an additional 201,667 shares during the last quarter. UBS Group AG raised its holdings in shares of Sabra Healthcare REIT by 143.1% during the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock worth $27,657,000 after purchasing an additional 859,584 shares during the last quarter. Finally, Lasalle Investment Management Securities LLC acquired a new position in Sabra Healthcare REIT during the fourth quarter valued at $66,938,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

SBRA opened at $22.36 on Monday. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $22.55. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The company has a fifty day moving average of $19.68 and a two-hundred day moving average of $19.84. The stock has a market capitalization of $5.64 billion, a price-to-earnings ratio of 35.49, a PEG ratio of 1.73 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business had revenue of $211.74 million during the quarter, compared to the consensus estimate of $209.20 million. During the same quarter in the prior year, the firm posted $0.37 earnings per share. The company’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 5.4%. Sabra Healthcare REIT’s dividend payout ratio is presently 190.48%.

Analyst Upgrades and Downgrades

Several research firms have commented on SBRA. Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Truist Financial boosted their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and a consensus price target of $22.25.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.